Company intelligence / Profile preview

Altruistic

Suzhou, Jiangsu, Chinaaltruisticac.com ↗

Ownership: Private
Employees: ~1300
Development stage: Other

Overview

Altruist Biologics is an active, leading China-based CDMO specializing in end-to-end development and large-scale GMP manufacturing of biopharmaceuticals including antibodies, fusion proteins, ADCs, gene therapies, and cell therapies. They have supported over 30 IND filings in China and internationally (including US/Australia), 8 NDAs in China, 1 BLA in the US, and currently manufacture four commercial antibody products with over 700 successful batches completed. Their facilities meet FDA/EMA/NMPA standards.

Modalities: Monoclonal antibodyAntibody-drug conjugateFusion proteinGene therapyCell therapy
Industry: Contract Manufacturing Organization

Partnerships

Global pharma/biotech clients

Beyond the preview

Go deeper on Altruistic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altruistic.

Explore the full profile